Paragangliomas Terminated Phase 2 Trials for Pazopanib (DB06589)

Also known as: Paraganglioma / Paraganglion neoplasm / Paraganglion neoplasm NOS / Neoplasm of paraganglion (disorder) / [M]Paraganglioma NOS (morphologic abnormality) / Gangliocytic paraganglioma (disorder) / Gangliocytic paraganglioma (morphologic abnormality) / Paraganglioma (morphologic abnormality) / Paraganglioma (disorder)

IndicationStatusPhase
DBCOND0051744 (Paragangliomas)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01340794Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or ParagangliomaTreatment